Allogeneic Transplantation of Unmanipulated Peripheral Blood Stem Cells in Patients With Multiple Myeloma

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1701362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma

Seminars in Hematology
Hematology
2009English

Peripheral Blood Stem Cells: A Novel Source for Allogeneic Transplantation

Oncologist
Cancer ResearchMedicineOncology
1997English

Nonmyeloablative Stem Cell Transplantation With CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Patients With Multiple Myeloma Develop SOX2-Specific Autoantibodies After Allogeneic Stem Cell Transplantation

Clinical and Developmental Immunology
2011English

Peripheral Blood Stem Cell Transplantation in a Multiple Myeloma Patient With End-Stage Renal Failure

Bone Marrow Transplantation
TransplantationHematology
1997English

Non-Myeloablative Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells: A Phase II Randomized Trial

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Matched-Pair Analysis of Peripheral Blood Stem Cells Compared to Marrow for Allogeneic Transplantation

Bone Marrow Transplantation
TransplantationHematology
2000English

Pneumoperitoneum Without Peritonitis After Allogeneic Peripheral Blood Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy